Garden State Investment Advisory Services LLC Invests $26,000 in Sharps Technology, Inc. (NASDAQ:STSS)

Garden State Investment Advisory Services LLC bought a new stake in Sharps Technology, Inc. (NASDAQ:STSSFree Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 172,909 shares of the company’s stock, valued at approximately $26,000. Garden State Investment Advisory Services LLC owned 0.10% of Sharps Technology as of its most recent filing with the Securities & Exchange Commission.

Sharps Technology Stock Up 2.5 %

NASDAQ STSS opened at $2.04 on Friday. The stock has a market cap of $3.67 million, a P/E ratio of -0.25 and a beta of 1.37. Sharps Technology, Inc. has a 1-year low of $1.70 and a 1-year high of $18.15. The company has a 50 day moving average price of $2.83.

Sharps Technology Company Profile

(Free Report)

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.

Featured Articles

Want to see what other hedge funds are holding STSS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sharps Technology, Inc. (NASDAQ:STSSFree Report).

Receive News & Ratings for Sharps Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Technology and related companies with MarketBeat.com's FREE daily email newsletter.